Category Archives: Cardiac Regeneration

November 18, 2020 07:00 ET | Source: Novoheart Holdings Inc. Continue reading →

SUWANEE, GA, Nov. 17, 2020 (GLOBE NEWSWIRE) viaNewMediaWireSANUWAVE Health, Inc. Continue reading →

5 foods that help you lose weight Heart diseases or Cardiovascular diseases (CVDs) is one of the leading causes of death across the world. This silent killer creeps up unsuspecting individuals and announces its domination often in the form of myocardial infarction (MI) or a heart attack. MI leaves the heart acutely damaged. Continue reading →

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. Continue reading →

Octapharma The report further sheds light on the various strategic business initiatives undertaken by the key market contenders to fortify their foothold in this business sector. These strategies majorly include mergers & acquisitions, partnerships & collaborations, joint ventures, government and corporate deals, brand promotions, new product launches, and numerous others. Continue reading →

CardioClusters use three types of cells to reduce scar tissue and improve function by integrating into and persisting within damaged heart tissue. Cell therapy for cardiac regeneration, while promising, has been hampered by issues with long-term survival of the transplanted cells. Now, a technique that combines three different types of cells in a 3D cluster could improve its efficacy in reducing scar tissue and improving cardiac function after a heart attack. Continue reading →

ROCKVILLE, Md., Sept. 8, 2020 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced today that a multi-institutional team of scientists from eight American research centers published a research paper on new therapeutic approaches for COVID-19 in which they propose that Thymosin beta 4 (T4), because of its ability to induce fibrinolysis, among other activities, may be useful in treating patients with the COVID-19 virus. Continue reading →

Zimmer Biomet For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999632 Key Market Trends: Cardiology is Expected to hold its Highest Market Share in the Application Segment In the application segment of the market, cardiology is believed to have the largest market size and is expected to witness a CAGR of 16.0% during the forecast period. Recent years have observed promising applications of polymeric biomaterials in cardiac repair and regeneration. Organ failure is also one among the major health problems, globally recognized Continue reading →

24.5 Million Covered Lives Now Eligible for Biologic Advanced Wound Care Treatment Through Centene Corporation SUWANEE, GA, Sept. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin, musculoskeletal tissue and vascular structures, announced today that Centene Corporation, the largest Medicare and Medicaid Administrator in the U.S., has included BIOVANCE® in its list of reimbursed skin substitutes for advanced wound healing for the more than 24.5 million lives it covers. Continue reading →

MIRAMAR, Fla., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation(www.generex.com) (OTCQB:GNBT) is pleased to announce that physicians at Yale University School of Medicine and the VA Connecticut Healthcare System have published a paper in the Journal of Vascular Surgery Cases and Innovative Techniques describing the use of Excellagen wound conforming collagen matrix as part of a hybrid surgical protocol to repair a femoral artery pseudoaneurysm Continue reading →